C66

Case	Control
124	460070

Location	SNP	Gene	Ref>Alt	Alt in Case	Alt in Control	Chi-square	P-value	Odds Ratio
chr12:53729388	rs189358282	SP7	G>T	12	10575	31.31	2.201e-08	4.52
chr1:20468047	rs79255115	PLA2G2F	G>C	16	16927	30.88	2.741e-08	3.799
chr22:46229891	rs117279738	ATXN10	C>T	24	33122	28.27	1.056e-07	2.964
chr1:239414810	rs12140251	-	T>C	19	23441	27.91	1.274e-07	3.284
chr9:105000593	rs112200384	-	T>G	22	29845	26.83	2.223e-07	3.003
chr6:63543722	rs76315198	-	C>T	14	15072	26.26	2.99e-07	3.718
chr2:61312235	rs75449561	KIAA1841	A>G	26	39352	25.22	5.107e-07	2.713
chr12:53722233	rs116856142	SP7	G>A	11	10645	24.66	6.83e-07	4.102
chr5:108415427	rs80235298	FER	A>T	11	10515	24.54	7.271e-07	4.09
chr5:162948205	rs116352364	-	T>C	13	14221	23.96	9.839e-07	3.674
chr2:197783391	rs75766689	PGAP1	G>A	12	12527	23.66	1.147e-06	3.809
chr2:197525487	rs57703734	CCDC150	A>G	12	12647	23.61	1.178e-06	3.805
chr8:137283400	rs62528665	-	G>A	22	31869	23.39	1.325e-06	2.809
chr16:85787677	rs75207933	-	G>A	12	12659	23.26	1.415e-06	3.771
chr6:114493211	rs72952568	HS3ST5	A>G	14	16177	23.1	1.539e-06	3.459
chr2:145285067	rs79391583	-	G>T	16	20034	22.64	1.955e-06	3.199
chr15:97889261	rs11631558	-	A>G	17	22063	22.52	2.082e-06	3.098
chr7:152279204	rs10267294	-	C>T	80	203823	22.18	2.482e-06	1.904
chr18:62031931	rs78089071	-	A>G	14	16603	21.89	2.881e-06	3.367
chr12:51567948	rs77629257	-	A>G	18	24487	21.63	3.304e-06	2.956
chr12:53729388	rs189358282	SP7	G>T	12	10429	30.26	3.772e-08	4.427
chr1:20468047	rs79255115	PLA2G2F	G>C	16	16549	30.21	3.882e-08	3.754
chr22:46229891	rs117279738	ATXN10	C>T	24	32357	27.59	1.5e-07	2.933
chr2:199103914	rs1563494	PLCL1	A>C	11	9635	27.38	1.672e-07	4.379
chr1:239414810	rs12140251	-	T>C	19	22889	27.31	1.734e-07	3.25
chr9:105000593	rs112200384	-	T>G	22	29369	25.8	3.795e-07	2.948
chr6:63543722	rs76315198	-	C>T	14	14790	25.51	4.398e-07	3.66
chr2:61312235	rs75449561	KIAA1841	A>G	26	38221	24.9	6.047e-07	2.7
chr2:47069035	rs72884735	-	C>T	14	15115	24.53	7.309e-07	3.579
chr5:108415427	rs80235298	FER	A>T	11	10267	24.06	9.34e-07	4.044
chr12:53722233	rs116856142	SP7	G>A	11	10480	23.87	1.031e-06	4.025
chr5:162948205	rs116352364	-	T>C	13	13894	23.47	1.266e-06	3.634
chr7:152279204	rs10267294	-	C>T	79	191799	23.33	1.367e-06	1.947
chr16:78490090	rs74335576	WWOX	G>T	12	12310	23.29	1.39e-06	3.778
chr14:68251934	rs3742884	ZFYVE26	G>A	13	14102	22.86	1.741e-06	3.579
chr16:85787677	rs75207933	-	G>A	12	12423	22.6	1.991e-06	3.712
chr8:137283400	rs62528665	-	G>A	22	31280	22.57	2.031e-06	2.765
chr1:245502722	rs6684741	KIF26B	A>C	60	127015	22.18	2.487e-06	1.984
chr6:114493211	rs72952568	HS3ST5	A>G	14	16007	22.07	2.633e-06	3.376
chr15:97889261	rs11631558	-	A>G	17	21619	21.86	2.932e-06	3.054

Location

SNP

Gene

Ref>Alt

Alt in Case

Alt in Control

Chi-square

P-value

Odds Ratio

chr12:53729388

rs189358282

SP7

G>T

12

10575

31.31

2.201e-08

4.52

chr1:20468047

rs79255115

PLA2G2F

G>C

16

16927

30.88

2.741e-08

3.799

chr22:46229891

rs117279738

ATXN10

C>T

24

33122

28.27

1.056e-07

2.964

chr1:239414810

rs12140251

-

T>C

19

23441

27.91

1.274e-07

3.284

chr9:105000593

rs112200384

-

T>G

22

29845

26.83

2.223e-07

3.003

chr6:63543722

rs76315198

-

C>T

14

15072

26.26

2.99e-07

3.718

chr2:61312235

rs75449561

KIAA1841

A>G

26

39352

25.22

5.107e-07

2.713

chr12:53722233

rs116856142

SP7

G>A

11

10645

24.66

6.83e-07

4.102

chr5:108415427

rs80235298

FER

A>T

11

10515

24.54

7.271e-07

4.09

chr5:162948205

rs116352364

-

T>C

13

14221

23.96

9.839e-07

3.674

chr2:197783391

rs75766689

PGAP1

G>A

12

12527

23.66

1.147e-06

3.809

chr2:197525487

rs57703734

CCDC150

A>G

12

12647

23.61

1.178e-06

3.805

chr8:137283400

rs62528665

-

G>A

22

31869

23.39

1.325e-06

2.809

chr16:85787677

rs75207933

-

G>A

12

12659

23.26

1.415e-06

3.771

chr6:114493211

rs72952568

HS3ST5

A>G

14

16177

23.1

1.539e-06

3.459

chr2:145285067

rs79391583

-

G>T

16

20034

22.64

1.955e-06

3.199

chr15:97889261

rs11631558

-

A>G

17

22063

22.52

2.082e-06

3.098

chr7:152279204

rs10267294

-

C>T

80

203823

22.18

2.482e-06

1.904

chr18:62031931

rs78089071

-

A>G

14

16603

21.89

2.881e-06

3.367

chr12:51567948

rs77629257

-

A>G

18

24487

21.63

3.304e-06

2.956

chr12:53729388

rs189358282

SP7

G>T

12

10429

30.26

3.772e-08

4.427

chr1:20468047

rs79255115

PLA2G2F

G>C

16

16549

30.21

3.882e-08

3.754

chr22:46229891

rs117279738

ATXN10

C>T

24

32357

27.59

1.5e-07

2.933

chr2:199103914

rs1563494

PLCL1

A>C

11

9635

27.38

1.672e-07

4.379

chr1:239414810

rs12140251

-

T>C

19

22889

27.31

1.734e-07

3.25

chr9:105000593

rs112200384

-

T>G

22

29369

25.8

3.795e-07

2.948

chr6:63543722

rs76315198

-

C>T

14

14790

25.51

4.398e-07

3.66

chr2:61312235

rs75449561

KIAA1841

A>G

26

38221

24.9

6.047e-07

2.7

chr2:47069035

rs72884735

-

C>T

14

15115

24.53

7.309e-07

3.579

chr5:108415427

rs80235298

FER

A>T

11

10267

24.06

9.34e-07

4.044

chr12:53722233

rs116856142

SP7

G>A

11

10480

23.87

1.031e-06

4.025

chr5:162948205

rs116352364

-

T>C

13

13894

23.47

1.266e-06

3.634

chr7:152279204

rs10267294

-

C>T

79

191799

23.33

1.367e-06

1.947

chr16:78490090

rs74335576

WWOX

G>T

12

12310

23.29

1.39e-06

3.778

chr14:68251934

rs3742884

ZFYVE26

G>A

13

14102

22.86

1.741e-06

3.579

chr16:85787677

rs75207933

-

G>A

12

12423

22.6

1.991e-06

3.712

chr8:137283400

rs62528665

-

G>A

22

31280

22.57

2.031e-06

2.765

chr1:245502722

rs6684741

KIF26B

A>C

60

127015

22.18

2.487e-06

1.984

chr6:114493211

rs72952568

HS3ST5

A>G

14

16007

22.07

2.633e-06

3.376

chr15:97889261

rs11631558

-

A>G

17

21619

21.86

2.932e-06

3.054

ID	Name	Top Correlation
HP: 0000069	Abnormality of the ureter	0/20
HP: 0000071	Ureteral stenosis	0/20
HP: 0000077	Abnormality of the kidney	0/20
HP: 0000079	Abnormality of the urinary system	0/20
HP: 0000118	Phenotypic abnormality	0/20
HP: 0000119	Abnormality of the genitourinary system	0/20
HP: 0000126	Hydronephrosis	0/20
HP: 0000152	Abnormality of head or neck	0/20
HP: 0000464	Abnormality of the neck	0/20
HP: 0000790	Hematuria	0/20
HP: 0000924	Abnormality of the skeletal system	0/20
HP: 0001197	Abnormality of prenatal development or birth	0/20
HP: 0001376	Limitation of joint mobility	0/20
HP: 0001387	Joint stiffness	0/20
HP: 0001939	Abnormality of metabolism/homeostasis	0/20
HP: 0002664	Neoplasm	0/20
HP: 0003110	Abnormality of urine homeostasis	0/20
HP: 0005986	Limitation of neck motion	0/20
HP: 0006000	Ureteral obstruction	0/20
HP: 0007379	Neoplasm of the genitourinary tract	0/20
HP: 0009725	Bladder neoplasm	0/20
HP: 0010786	Urinary tract neoplasm	0/20
HP: 0010935	Abnormality of the upper urinary tract	0/20
HP: 0010944	Abnormal renal pelvis morphology	0/20
HP: 0010945	Fetal pyelectasis	0/20
HP: 0010946	Dilatation of the renal pelvis	0/20
HP: 0011277	Abnormality of the urinary system physiology	0/20
HP: 0011425	Fetal ultrasound soft marker	0/20
HP: 0011729	Abnormality of joint mobility	0/20
HP: 0011793	Neoplasm by anatomical site	0/20
HP: 0011843	Abnormality of skeletal physiology	0/20
HP: 0012210	Abnormal renal morphology	0/20
HP: 0012211	Abnormal renal physiology	0/20
HP: 0012531	Pain	0/20
HP: 0012587	Macroscopic hematuria	0/20
HP: 0012614	Abnormal urine cytology	0/20
HP: 0025142	Constitutional symptom	0/20
HP: 0025238	Foot pain	0/20
HP: 0025258	Stiff neck	0/20
HP: 0025634	Abnormal ureter physiology	0/20
HP: 0030157	Flank pain	0/20

Malignant neoplasm of ureter

C66

Case/Control GWAS ^ⓘ

Links

Statistics

Top SNP Information

Associated Phenotypes ^ⓘ

Malignant neoplasm of ureter

C66

Case/Control GWAS ⓘ

Links

Statistics

Top SNP Information Show Table

Associated Phenotypes ⓘ Shared SNP phenotypes No shared SNP phenotypes

Case/Control GWAS ^ⓘ

Top SNP Information

Associated Phenotypes ^ⓘ